Related Experiment Videos

Maternal serum screening for fetal Down syndrome: clinical aspects

D N Saller¹, J A Canick

¹Strong Memorial Hospital, University of Rochester School of Medicine, New York, USA.

Clinical Obstetrics and Gynecology

|December 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2009

Inhibin A measurement using an automated assay platform.

Prenatal diagnosis·2008

First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.

Prenatal diagnosis·2006

Inhibins and activins in human fetal abnormalities.

Molecular and cellular endocrinology·2004

Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia.

Diabetes care·2001

Maternal serum levels of type I and type III procollagen peptides in pre-eclamptic pregnancy.

The Journal of maternal-fetal medicine·2001

See all related articles